Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 5, 2000 - Issue 4
Submit an article Journal homepage
464
Views
37
CrossRef citations to date
0
Altmetric
Miscellany

Role of eosinophil peroxidase in the origins of protein oxidation in asthma

S.N. MitraDepartment of Cell Biology Cleveland Clinic Foundation, Cleveland , Ohio, USA
,
A. SlungaardDepartment of Internal Medicine University of Minnesota Medical School, Minneapolis, Minnesota, USA
&
S.L. HazenChemistry Department Cleveland State University, Cleveland , Ohio, USA
Pages 215-224 | Published online: 19 Jul 2013

  • Venge P, Dahl R. The eosinophil and intrinsic asthma. Agents Actions 1989; 28: 67–74.
  • Gleich GJ, Ottesen EA, Leiferman KM, Ackerman SJ. Eosinophils and human disease. Int Arch Allergy Appl Immunol 1989; 88: 59–62.
  • Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998; 50: 515–596.
  • Wardlaw AJ. Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J 1994; 70: 536–552.
  • Horwitz RJ, Busse WW. Inflammation and asthma. Clin Chest Med 1995; 16: 583–602.
  • Rothenburg ME. Eosinophilia. N Engl J Med 1998; 338: 1592–1600.
  • Holgate ST. The epidemic of allergy and asthma. Nature 1999; 402 ( Suppl.): B2-B4.
  • Ehrlich P. Ueber die specifischen granulationen des Blutes. Arch Arzat Physiol Lp 3 Physiol Abt 1879; 571-579.
  • Gollasch. Zurkenntnis des asthatischen sputums. Fortschr Med 1889; 7: 28.
  • Hamann KJ, Barker RL, Ten RM, Gleich GJ. The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol 1991; 94: 202–209.
  • Monteseirin J, Prados M, Bonilla let al. Granular proteins of eosinophils. Allergol Immunopathol 1996; 24: 219–225.
  • Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990; 142: 642–647.
  • Griffin E, Hakansson L, Formgren H, Jorgensen K, Peterson C, Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991; 87: 548–557.
  • Sanz ML, Parra A, Prieto I, Dieguez I, Oehling AK. Serum eosinophil peroxidase (EPO) levels in asthmatic patients. Allergy 1997; 52: 417–422.
  • Brottman GM, Regelmann WE, Slungaard A, Wangensteen OD. Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig. Pediatr Pulmonol 1996; 21: 159–166.
  • Yoshikawa S, Kayes SG, Parker JC. Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and vasoconstriction unaffected by eosinophil peroxidase inhibition. Am Rev Respir Dis 1993; 147: 914–920.
  • Pretolani M, Ruffle C, Joseph D et al. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med 1994; 149: 1167–1174.
  • Hamann KJ, Strek ME, Baranowski SL et al. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am J Physiol 1993; 265: L301–L307.
  • Minnicozzi M, Duran WN, Gleich GJ, Egan RW. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 1994; 153: 2664–2670.
  • Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991; 87: 1470–1473.
  • Dalde'n SE, Hedquist P, Hammarstrom S, Sammelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288: 484–486.
  • Shaw RJ, Cromwell 0, Kay AB. Preferential generation of leukotriene C4 by human eosinophils. Clin Exp Immunol 1984; 56: 716.
  • Shaw RJ, Walsh GM, Cromwell 0, Moqbel R, Spry CJF, Kay AB. Activated human eosinophils generate SRS-A leukotrienes following physiological (IgG dependent) stimulation. Nature 1985; 316: 150–152.
  • Bruijnzeel PL. Contribution of eosinophil-derived mediators in asthma. Int Arch Allergy Appl Immunol 1989; 90 (Suppl. 1): 57-63.
  • Kazura JW, Fanning MM, Blumer JL, Mahmoud AA. Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest 1981; 67: 93–102.
  • Klebanoff SJ, Locksley RM, Jong EC, Rosen H. Oxidative response of phagocytes to parasite invasion. Ciba Found Symp 1983; 99: 92–112.
  • Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanism: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973; 52: 741–744.
  • Jong EC, Henderson WR, Klebanoff SJ. Bactericidal activity of eosinophil peroxidase. J Immunol 1980; 124: 1378–1382.
  • Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170–200.
  • DeChatelet LR, Shirley PS, McPhail LC, Huntley CC, Muss HB, Bass DA. Oxidative metabolism of the human eosinophil. Blood 1977; 50: 525–535.
  • Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 1990; 171: 2025–2041.
  • Someya A, Nishijima K, Nunoi H, Irie S, Nagaoka I. Study on the superoxide-producing enzyme of eosinophils and neutrophils - comparison of the NADPH oxidase components. Arch Biochem Biophys 1997; 345: 207–213.
  • Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988; 263: 3550–3553.
  • Kimura S, Ikeda-Saito M. Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family. Proteins Struct Funct Genet 1988; 3: 113–120.
  • Cals MM, Maillart P, Brignon G, Anglade P, Dumas BR. Primary structure of bovine lactoperoxidase, a fourth member of a mammalian heme peroxidase family. Eur J Biochem 1991; 198: 733–739.
  • Ten RM, Pease LR, McKean DJ, Bell MP, Gleich GJ. Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxide superfamily. J Exp Med 1989; 169: 1757–1769.
  • Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 2000; In press.
  • Jong EC, Klebanoff SJ. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system. J Immunol 1980; 124: 1949–1953.
  • Agosti JM, Altman LC, Ayars Gil, Loegering DA, Gleich GJ, Klebanoff SJ. The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J Allergy Clin Immunol 1987; 79: 496–504.
  • Ayars Gil, Altman LC, McManus MM et al. Injurious effect of the eosinophil peroxidase-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis 1989; 140: 125–131.
  • Slungaard A, Mahoney JR Jr. Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis. J Exp Med 1991; 173: 117–126.
  • Samoszuk MK, Nguyen V, Thomas C, Jacobson D. Effects of sonicated eosinophils on the in vivo sensitivity of human lymphoma cells to glucose oxidase. Cancer Res 1994; 54: 2650–2653.
  • Anni H, Yonetani T. Mechanism of action of peroxidases. Met Ions Biol Syst 1992; 28: 219–241.
  • Dunford HB. Peroxidases. Adv Inorg Biochem 1982; 4: 41–68.
  • Finzel BC, Poulos TS, Kraut J. Crystal structure of yeast cytochrome c peroxidase refined at 1.7 A resolution. J Biol Chem 1984; 259: 13027–13036.
  • Dawson JH. Probing structure-function relations in heme-containing oxygenases and peroxidases. Science 1988; 240: 433–439.
  • Monzani E, Gatti AL, Profumo A, Casella L, Gullotti M. Oxidation of phenolic compounds by lactoperoxidase. Evidence for the presence of a low-potential compound II during catalytic turnover. Biochemistry 1997; 36: 1918–1926.
  • Courtin F, Deme D, Virion A, Michot J-L, Pommier J, Nunez J. The role of lactoperoxidase-I1202 compounds in the catalysis of thyroglobulin iodination and thyroid hormone synthesis. Eur J Biochem 1982; 124: 603–609.
  • Courtin F, Michot J-L, Virion A, Pommier J, Deme D. Reduction of lactoperoxidase-H202 compounds by ferrocyanide: indirect evidence of an apoprotein site for one of the two oxidizing equivalents. Biochem Biophys Res Commun 1984; 121: 463–470.
  • Hori H, Fenna RE, Kimura S, Ikeda-Saito M. Aromatic substrate molecules bind at the distal heme pocket of myeloperoxidase. J Biol Chem 1994; 269: 8388–8392.
  • Fiedler TJ, Davey CA, Fenna RE. X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J Biol Chem 2000; 275: 11964–11971.
  • Slungaard A, Mahoney JR Jr. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. J Biol Chem 1991; 266: 4903–4910.
  • Weiss SJ, Test ST, Eckmann CM, Ross D, Regiania S. Brominating oxidants generated by human eosinophils. Science 1986; 234: 200–203.
  • Mayeno AN, Curran AJ, Roberts RL, Foote CS. Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem 1989; 264: 5660–5668.
  • Wu W, Samoszuk MK, Comhair SAA et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000; 105: 1455–1463.
  • van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 1997; 327: 487–492.
  • Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. In review.
  • Thomas EL, Bozeman PM, Jefferson MM, King CC. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromoamines. J Biol Chem 1995; 270: 2906–2913.
  • Linder M. Nutritional Biochemistry and Metabolism. New York, NY: Elsevier, 1992; 98.
  • Teitz NW. Drugs: therapeutic and toxic. In: Burris CA, Ashwood ER. (eds) Teitz Textbook of Clinical Chemistry. Philadelphia, PA: Saunders, 1999; 1097.
  • Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996; 98: 1283–1289.
  • Hazen SL, Crowley JR, Mueller DM, Heinecke JW. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic Biol Med 1997; 23: 909–916.
  • Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic J Clin Invest 1997; 99: 2075-2081.
  • Kettle AJ. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett 1996; 379: 103–106.
  • Wu W, Chen Y, d'Avignon A, Hazen SL. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 1999; 38: 3538-3548.
  • Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 1995; 270: 16542–16548.
  • Albrich JM, McCarthy CA, Hurst JK. Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci USA 1981; 78: 210–214.
  • Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 1976; 251: 1371–1374.
  • Hazen SL, Gaut JP, Hsu FF, Crowley JR, d'Avignon A, Heinecke JW. p-Hydroxyphenylacetaldehyde, the major product of L-tyrosine oxidation by the myeloperoxidase-I1202-chloride system of phagocytes, covalently modifies epsilon-amino groups of protein lysine residues. J Biol Chem 1997; 272: 16990–16998.
  • Hazen SL, Crowley JR, Mueller DM, Heinecke JW. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic Biol Med 1997; 23: 909–916.
  • Kettle AJ, Winterbourn CC. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol 1994; 233: 502–512.
  • Grisham MB, Jefferson MM, Melton DF, Thomas EL. Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 1984; 259: 10404–10413.
  • Marquez LA, Dunford HB. Chlorination of taurine by myeloperoxidase. Kinetic evidence for an enzyme-bound intermediate. J Biol Chem 1994; 269: 7950–7956.
  • Wajon JE, Morris JC. Bromination chemistry: rates of formation of NH2Br and some N-brominated amino acids. In: Jolley RL, Brungs WA, Cumming RB, Jacobs VA. (eds) Water Chlorination: Environmental Impact and Health Effects, vol. 3. Ann Arbor, MI: Ann Arbor Science, 1980; 171-181.
  • Kanofsky JR. Bromine derivatives of amino acids as intermediates in the peroxidase-catalyzed formation of singlet oxygen. Arch Biochem Biophys 1989; 274: 229–234.
  • Kanofsky JR, Hoogland H, Weyer R, Weiss SJ. Singlet oxygen production by human eosinophils. J Biol Chem 1988; 263: 9692–9696.
  • Hazen SL, d'Avignon A, Anderson MM, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J Biol Chem 1998; 273: 4997–5005.
  • Hazen SL, Hsu FF, d'Avignon A, Heinecke JW. Human neutrophils employ myeloperoxidase to convert a-amino acids to a battery of reactive aldehydes: a pathway for aldehyde formation at sites of inflammation. Biochemistry 1998; 37: 6864–6873.
  • Wajon JE, Morris JC. Rates of formation of N-bromo amines in aqueous solution. Inorg Chem 1982; 21: 4258–4263.
  • Hazen SL, Hsu FF, Heinecke JW. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: a chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J Biol Chem 1996; 271: 1861–1867.
  • de la Mare PBD, Ridd JH. Aromatic Substitution: Nitration and Halogenation. London: Butterworth, 1959; 105–129.
  • MacPherson JC, Comhair SA, Erzurum SC et al. Eosinophils are a major source of NO-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. In review.
  • Carr AC, van den Berg JJ, Winterbourn CC. Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipid: formation of haloamines and halohydrins. Biochim Biophys Acta 1998; 1392: 254–264.
  • Shen A, Mitra SN, Wu W et al. Eosinophil peroxidase brominates free nucleotides and double stranded DNA: identification of novel markers for oxidative damage. In review.
  • Hazen SL, Hsu FF, Duffin K, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem 1996; 271: 23080–23088.
  • Hazen SL, Hsu FF, Gaut JP, Crowley JR, Heinecke JW. Modification of proteins and lipids by myeloperoxidase. Methods Enzymol 1999; 300: 88–105.
  • Henderson JP, Byun J, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 1999; 274: 33440–33448.
  • Ramos CL, Pou S, Britigan BE, Cohen MS, Rosen GM. Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem 1992; 267: 8307–8312.
  • McCormick ML, Roeder TL, Railsback MA, Britigan BE. Eosinophil peroxidase-dependent hydroxyl radical generation by human eosinophils. J Biol Chem 1994; 269: 27914–27919.
  • Subrahmanyam VV, Kolachana P, Smith MT. Hydroxylation of phenol to hydroquinone catalyzed by a human myeloperoxidase-superoxide complex: possible implications in benzene-induced myelotoxicity. Free Radic Res Commun 1991; 15: 285–296.
  • Candeias LP, Patel KB, Stratford MR, Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett 1993; 333: 151–153.
  • Long CA, Bielski BHT. Rate of reaction of superoxide radical with chloride-containing species. J Phys Chem 1980; 84: 555–557.
  • Ross AB, Mallard NG, Helman WP, Bielski BHT, Buxton GV. NDRL-NIST Solution Kinetics Database, ver. 1.1999.
  • Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000; 39: 5474–5482.
  • Kaplan RP. Cancer complicating chronic ulcerative and scarifying mucocutaneous disorders. Adv Dennatol 1987; 2: 19–46.
  • Gordon LI, Weitzman SA. The respiratory burst and carcinogenesis. In: Sbarra AJ, Strauss RR. (eds) The Respiratory Burst and its Physiological Significance. New York, NY: Plenum, 1988; 277–298.
  • Preston-Martin S, Pike MC, Ross RIC, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1991; 50: 7415–7421.
  • Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994; 54: 1929s-1933s.
  • Sithithaworn P, Haswell-Elkins MR, Mairiang P et al. Parasite-associated morbidity: liver fluke infection and bile duct cancer in north-east Thailand. Int J Parasitol 1994; 24: 833–843.
  • Haswell-Elkins MR, Satarug S, Tsuda M et al. Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. Mutat Res 1994; 305: 241–252.
  • Ishii A, Matsuoka H, Aji T et al. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). Mutat Res 1994; 305: 273–281.
  • Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74: 297–312.
  • Aune TM, Thomas EL, Morrison M. Lactoperoxidase-catalyzed incorporation of thiocyanate ion into a protein substrate. Biochemistry 1977; 16:4611.
  • Thomas EL, Fishman M. Oxidation of chloride and thiocyanate by isolated leukocytes. J Biol Chem 1986; 261: 9694–9702.
  • Thomas EL. Products of lactoperoxidase-catalysed oxidation of thiocyanate. In: Pruitt KM, Tenovou JO. (eds) The Lactoperoxidase System, Chemistry and Biological Significance. New York, NY: Marcel Dekker, 1985; 31–53.
  • Modi S, Deodhar SS, Behere DV, Mitra S. Lactoperoxidase-catalyzed oxidation of thiocyanate by hydrogen peroxide: “N nuclear magnetic resonance and optical spectral studies. Biochemistry 1991; 30: 118–124.
  • Pollock JR, Goff HM. Lactoperoxidase-catalyzed oxidation of thio-cyanate ion: a carbon-13 nuclear magnetic resonance study of the oxidation products. Biochim Biophys Acta 1992; 1159: 279–285.
  • Lovaas E. Free radical generation and coupled thiol oxidation by lactoperoxidase/SCN/11202. Free Radic Biol Med 1992; 13: 187–195.
  • Arlandson M, Decker T, Roongta VA et al. Eosinophil peroxidase oxidation of thiocyanate: characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. In review.
  • Stark GR. Modification of proteins with cyanate. Methods Enzymol 1967; 11: 590–594.
  • Barnes PJ. Nitric oxide and asthma. Res Immunol 1995; 146: 698–702.
  • Sanders SP. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? Am J Respir Cell Mol Biol 1999; 21: 147–149.
  • Ashutosh K. Nitric oxide and asthma: a review. Curr Opin Pulm Med 2000; 6: 21–25.
  • Guo FH, Comhair SAA, Zheng S et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 2000; 164: 5970–5980.
  • Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues: implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999; 274: 25933–25944.
  • van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997; 272: 7617–7625.
  • Burner U, Furtmiiller PG, Kettle AJ, Koppenol WH, Obinger C. Mechanism of reaction of myeloperoxidase with nitrite. J Biol Chem 2000; 275: 20597–20601.
  • Schmitt D, Shen Z, Mang R et al. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry 1999; 38: 16904–16915.
  • Hazen SL, Mang R, Shen Z et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 1999; 85: 950–958.
  • Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 1999; 103: 1547-1560.
  • Podrez EA, Febbraio M, Sheibani Net al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 2000; 105: 1095–1108
  • MacPherson J, Hazen SL. Eosinophil peroxidase generates bioactive eicosanoids via formation of reactive nitrogen species. Free Radic Biol Med 1999; 27 ( Suppl.): S95.
  • Stelts D, Egan RW, Falcone A et al. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol 1998; 18: 463–470.
  • Nauseef WM. Myeloperoxidase deficiency. Hematol Pathol 1990; 4: 165–178.
  • Presentey B, Joshua H. Peroxidase and phospholipid deficiency in human eosinophil granulocytes — a marker in population genetics. Experientia 1982; 38: 628–629.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.